Deep Brain Stimulation — CPB 0208 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0208 covering deep brain stimulation, effective September 26, 2025. Here's what billing teams need to do.

Aetna's deep brain stimulation coverage policy under CPB 0208 Aetna system was updated on September 26, 2025. The policy covers a wide set of CPT and HCPCS codes — including 61863, 61885, 61886, and the full L8680–L8688 equipment code range — for conditions ranging from Parkinson's disease tremor to intractable dystonia and refractory epilepsy. If your practice bills for DBS implantation, device management, or neurostimulator programming, this policy governs your Aetna reimbursement and what triggers a claim denial.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Deep Brain Stimulation — CPB 0208
Policy Code	CPB 0208
Change Type	Modified
Effective Date	September 26, 2025
Impact Level	High
Specialties Affected	Neurosurgery, Neurology, Movement Disorder Programs, Epilepsy Centers, DME billing
Key Action	Audit all active DBS prior authorization requests and charge capture against the updated medical necessity criteria before billing any claims with a date of service on or after September 26, 2025

---

Aetna Deep Brain Stimulation Coverage Criteria and Medical Necessity Requirements 2025

Aetna's coverage policy for deep brain stimulation is not a simple yes/no. It's a tiered, indication-specific framework. Each indication has its own checklist, and if one criterion is missing from the documentation, you're looking at a denial.

There are four covered indications under CPB 0208. Each one has hard requirements. Know them before you submit.

Indication 1: Intractable Tremor from Parkinson's Disease or Essential Tremor

Aetna covers unilateral or bilateral DBS — targeting the ventral intermediate thalamic nucleus, globus pallidus, or subthalamic nucleus — when all five of the following are documented:

Hoehn and Yahr Stage V is a hard exclusion. Aetna defines it as a cachectic state where the member cannot stand or walk, is bedridden, and requires constant nursing care. If your patient is at Stage V, DBS is not covered under this indication. Document the staging explicitly in the prior authorization request.

Indication 2: Severe, Refractory Motor Complications of Parkinson's Disease

This is the indication most likely to generate medical necessity disputes. The criteria are stricter and more quantified:

The UPDRS score requirement is the piece most often missing from prior auth submissions. "Off medication" means approximately 12 hours without levodopa. Make sure the neurologist documents the specific score and the washout period. Aetna will ask for it.

Indication 3: Intractable Primary Dystonia (Age 7 and Older)

Aetna covers unilateral or bilateral DBS targeting the globus pallidus or subthalamic nucleus for members 7 years of age or older with intractable primary dystonia. This covers generalized dystonia, segmental dystonia, hemidystonia, and cervical dystonia.

This is one of the cleaner medical necessity determinations in the policy. The age threshold (7 and older) and the "primary" dystonia requirement are the key gatekeepers. Secondary dystonia — caused by structural, metabolic, or degenerative conditions — is not addressed here. If you're billing for a pediatric DBS case, this is the indication to work from.

Indication 4: Partial Onset Seizures / Refractory Epilepsy (Adults 18 and Older)

Aetna covers bilateral stimulation of the anterior nucleus of the thalamus — using a system like the Medtronic DBS System for Epilepsy — for adults 18 and older who meet all of the following:

The policy explicitly notes this has not been evaluated for patients with less frequent seizures. Aetna will not pay for anterior thalamic stimulation outside these parameters. If your epilepsy center is billing CPT 61885 or 61886 for this indication, document the seizure frequency and the medication history in full.

Pre-Operative Brain MRI

Aetna also covers brain MRI with or without contrast (CPT 70551, 70552, or 70553) as medically necessary for pre-operative planning or intra-operative navigation for DBS implantation. This is a straightforward covered service. Tie the MRI order to the DBS indication in your documentation.

---

Aetna Deep Brain Stimulation Exclusions and Non-Covered Indications

The policy's exclusions operate at two levels: patient-level disqualifiers and indication-level limits.

At the patient level, these conditions disqualify a member from coverage across all DBS indications: dementia, severe depression, cerebral atrophy, and Hoehn and Yahr Stage V Parkinson's disease. These aren't soft contraindications — Aetna treats them as hard coverage exclusions.

At the indication level, the epilepsy DBS benefit doesn't extend to patients with less frequent seizures (fewer than six per month or more than 30 days between events). The policy is explicit that this population simply hasn't been studied under Aetna's evidence standard.

Secondary dystonia is not listed as a covered indication. Only primary dystonia qualifies under the dystonia benefit. If the dystonia is secondary to another condition, you don't have a covered indication under this policy.

---

Coverage Indications at a Glance

---

Aetna Deep Brain Stimulation Billing Guidelines and Action Items 2025

This policy governs a high-dollar, high-complexity procedure. Denials here aren't a nuisance — they're revenue cycle events that take months to resolve. Get the documentation right before the claim goes out.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Deep Brain Stimulation Under CPB 0208

Covered CPT Codes (When Selection Criteria Are Met)

Covered HCPCS Codes (When Selection Criteria Are Met)

Key ICD-10-CM Diagnosis Codes

The full ICD-10 list under CPB 0208 spans 289 codes. These are the highest-volume categories your deep brain stimulation billing team will use:

The full ICD-10 code list — all 289 codes — is available in the CPB 0208 Aetna policy record at app.payerpolicy.org/p/aetna/0208. The dementia and focal lesion codes matter most for claim denial risk. Use them to flag cases where DBS is not covered before the claim goes out.

---